Cargando…
Increased Expression of PPAR-γ Modulates Monocytes Into a M2-Like Phenotype in SLE Patients: An Implicative Protective Mechanism and Potential Therapeutic Strategy of Systemic Lupus Erythematosus
Systemic lupus erythematosus (SLE) is a spectrum of autoimmune disorders characterized by continuous inflammation and the production of autoantibodies. Monocytes, as precursors of dendritic cells and macrophages, are involved in the pathogenesis of SLE, particularly in the inflammatory reactions. Pr...
Autores principales: | Liu, Yu, Luo, Shuangyan, Zhan, Yi, Wang, Jiayu, Zhao, Rui, Li, Yingjie, Zeng, Jinrong, Lu, Qianjin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873911/ https://www.ncbi.nlm.nih.gov/pubmed/33584646 http://dx.doi.org/10.3389/fimmu.2020.579372 |
Ejemplares similares
-
The roles of PPARγ and its agonists in autoimmune diseases: A comprehensive review
por: Liu, Yu, et al.
Publicado: (2020) -
Pauci-immune Glomerulonephritis in Systemic Lupus Erythematosus (SLE)
por: Liebowitz, Jason, et al.
Publicado: (2018) -
Sex Differences in Monocyte Activation in Systemic Lupus Erythematosus (SLE)
por: Jiang, Wei, et al.
Publicado: (2014) -
Immunomodulatory Effects of Diet and Nutrients in Systemic Lupus Erythematosus (SLE): A Systematic Review
por: Islam, Md Asiful, et al.
Publicado: (2020) -
A High Prevalence of Anti-EBNA1 Heteroantibodies in Systemic Lupus Erythematosus (SLE) Supports Anti-EBNA1 as an Origin for SLE Autoantibodies
por: Laurynenka, Viktoryia, et al.
Publicado: (2022)